Mutations in isocitrate dehydrogenase have been linked to elevated levels of HIF-1α and vascular endothelial growth factor (VEGF), which promote tumor progression and metastasis, while high levels of 2-hydroxyglutaric acid inhibit stem cell differentiation [25]. This evidence concerns the gene VEGFA and neoplasm.